“Comparison Of Sofosbuvir Plus Daclatsvir With Sofosbuvir Alone In Achieving Svr In Dialysis Dependent Chronic Hepatitis C Patients” (2023) Journal of Pharmaceutical Negative Results, pp. 3172–3179. doi:10.47750/pnr.2023.14.03.397.